Primary Renal Ewing Sarcoma in Children and Young Adults.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
14
4
2020
medline:
4
2
2021
entrez:
14
4
2020
Statut:
ppublish
Résumé
The Ewing sarcoma family of tumors (ESFT) are high-grade small round blue cell malignancies traditionally presenting in children and adolescents. The most common site of primary disease is bone, though extraskeletal primary sites are well-recognized. We present 6 cases of primary ESFT of the kidney and 1 case of the adrenal gland. Patients were 11 to 18 years of age at diagnosis. Metastases at diagnosis were present in most cases (n=6). All patients underwent surgery, and most received radiation (n=5). Five patients relapsed after initial remission. Comprehensive review of the primary renal ESFT literature was used to analyze various factors, including age, sex, disease metrics, metastases at diagnoses, and overall survival in a total of 362 cases. Notably, while the general ESFT population has reported rates of metastasis at diagnosis of 20% to 25%, this rate in the renal ESFT population was 53% with a rate of 59% in adolescent and young-adult patients (11 to 24 y). Nodal disease at diagnosis was present in 24% of renal ESFT cases compared with 3.2% in patients with primary skeletal ESFT. While this malignant process may share histologic and molecular features with its bone and soft tissue counterparts, primary renal ESFT presentations seem to be more aggressive and have worse outcomes.
Identifiants
pubmed: 32282650
doi: 10.1097/MPH.0000000000001804
pmc: PMC7554078
mid: NIHMS1578401
pii: 00043426-202011000-00004
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
474-481Subventions
Organisme : NHLBI NIH HHS
ID : T32 HL086345
Pays : United States
Références
Radiographics. 2016 Sep-Oct;36(5):1533-8
pubmed: 27618327
Fetal Pediatr Pathol. 2016;35(4):251-9
pubmed: 27182845
J Clin Oncol. 2019 Dec 1;37(34):3192-3202
pubmed: 31553693
Pediatr Blood Cancer. 2012 Oct;59(4):617-20
pubmed: 22184129
Int Urol Nephrol. 2006;38(3-4):775-8
pubmed: 17111087
Indian J Med Paediatr Oncol. 2017 Oct-Dec;38(4):538-541
pubmed: 29333026
J Clin Oncol. 2012 Nov 20;30(33):4148-54
pubmed: 23091096
Turk Patoloji Derg. 2018;34(3):251-254
pubmed: 28272661
J Clin Oncol. 2018 Sep 6;:JCO2018782516
pubmed: 30188789
Int J Clin Oncol. 2010 Jun;15(3):314-8
pubmed: 20198399
BMJ Case Rep. 2011 Dec 20;2011:
pubmed: 22669992
Am J Surg Pathol. 2016 Sep;40(9):1298-301
pubmed: 27340751
World J Surg Oncol. 2014 Sep 22;12:293
pubmed: 25242447
Urol Int. 2016;97(3):365-368
pubmed: 27035149
J Clin Oncol. 2010 Jul 10;28(20):3284-91
pubmed: 20547982
Urology. 2017 Jan;99:e11-e13
pubmed: 27720971
Lancet Oncol. 2010 Feb;11(2):184-92
pubmed: 20152770
Ann Oncol. 2013 Sep;24(9):2455-61
pubmed: 23761687
J Cytol. 2009 Jan;26(1):1-10
pubmed: 21938141
Pathology. 2016 Jan;48(1):47-50
pubmed: 27020209
Case Rep Radiol. 2014;2014:283902
pubmed: 24523977
Oncol Lett. 2015 Jan;9(1):108-112
pubmed: 25435942
J Clin Oncol. 2015 Sep 20;33(27):3036-46
pubmed: 26304893
Pathol Oncol Res. 2018 Jan;24(1):153-159
pubmed: 28429277
Mod Pathol. 2016 Apr;29(4):370-80
pubmed: 26847175